Medline (MDLN) said Thursday that certain selling stockholders closed an upsized secondary offering of 72.6 million shares of Class A common stock at $37.00 per share.
The selling stockholders also granted underwriters a 30-day option to purchase up to an additional 10.9 million shares.
Medline said it did not sell any shares in the offering and will not receive any proceeds.